Drugmaker Merck to pay $24M to settle Medicaid case

NewsGuard 100/100 Score

The drugmaker has agreed to settle a civil lawsuit that accused a former subsidiary of overpaying pharmacists for a widely used medication.

The Associated Press/Washington Post: Drugmaker Merck Agrees To Pay Massachusetts $24M To Settle Medicaid Fraud Claims
Drugmaker Merck & Co. will pay Massachusetts $24 million to settle a civil lawsuit accusing a former subsidiary of causing the state to overpay pharmacists for a widely used asthma medication. Attorney General Martha Coakley said Tuesday that the deal with Merck and 12 other drugmakers who settled previously enables the state to recover more than $47 million for its Medicaid program (12/20).

Boston Globe: Merck To Pay $24M In Overcharging Case
Merck & Co. has agreed to pay $24 million to the state Medicaid program to settle long-running civil charges that it charged too much for some drugs, in the largest single-case Medicaid fraud settlement in Massachusetts history. The agreement, unveiled yesterday by Attorney General Martha Coakley's office, closes out a 2003 lawsuit filed against 13 drug makers over inflated prices for medicines that were sold in pharmacies (Weisman, 12/21).

WBUR: Merck Settles Mass. Lawsuit For $24M
The giant pharmaceutical company Merck has agreed to pay the state $24 million to settle a lawsuit. Attorney General Martha Coakley sued Merck and 12 other drug companies on grounds that they had defrauded Medicaid by reporting inflated prices (12/20).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study suggests treating anxiety and depression significantly reduces ER visits and rehospitalizations among heart disease patients